Âé¶¹Ó°Òô

Skip to main content
  • Partnerships
  • Visit
  • Contact
Oak Ridge National Laboratory Oak Ridge National Laboratory
Menu
  • Âé¶¹Ó°Òô
    • Biology & Environment
    • Energy Science
    • Fusion & Fission
    • Isotopes
    • Physical Sciences
    • National Security
    • Supercomputing
  • Work With Us
    • User Facilities
  • About Us
    • Overview
    • Leadership Team
    • Initiatives
    • Visiting ORNL
    • Our Values
    • Community
    • History
    • Fact Sheets
    • Virtual Tour
  • News
Hit enter to search or ESC to close
Paul Benny

Paul Benny

Interim Group Lead, REDC Chemical Operations

Contact

BENNYPD@ORNL.GOV

Publications

June 2024

Development of 225Ac-doped biocompatible nanoparticles for targeted alpha therapy

Journal: Journal of Nanobiotechnology
August 2022

Elucidating the coordination chemistry of the radium ion for targeted alpha therapy

Journal: Chemical Communications
January 2021

Rapid Dissolution of PuO2 Analytical Samples using Mediated Electrochemical Oxidation

Journal: Journal of Radioanalytical and Nuclear Chemistry
February 2019

Initial Testing of Mediated Electrochemical Oxidation for Inclusion in the Plutonium-238 Production…

Conference Paper
View All

Key Links

Organizations

Isotope Science and Enrichment Directorate
Radioisotope Science and Technology Division
Radioisotope Production Engineering and Analysis Section
Technical Services, Finishing, and Dispensing Group
Isotope Processing and Manufacturing Division

Related News

News

Cancer-fighting chemistry

News

ORNL meets key FDA milestone for cancer-fighting Ac-225 isotope
Oak Ridge National Lab logo

Oak Ridge National Laboratory
1 Bethel Valley Road
Oak Ridge, TN 37830

(+1) 865.576.7658

Connect With Us

  • Partnerships
  • Visit
  • Contact

News

  • Newsroom
  • Media Contacts

Research

  • Âé¶¹Ó°Òô
  • User Facilities
  • Centers & Institutes

Resources

  • Internal Users
  • Directory
Oak Ridge National Laboratory is Âé¶¹Ó°Òô for the US Department of Energy
  • Privacy
  • Accessibility/508
  • Nondiscrimination/1557